Pyrotinib Maleate | Interleukin Related interleukin-related.com

Product Name :
Pyrotinib Maleate

Search keywords :
Pyrotinib dimaleate

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-4

Target Vo Short Name :
HER4

Moa_Name:
Receptor protein-tyrosine kinase erbB-4 antagonists

First Approval Country :
Mainland China

First Approval Date Filter:
2018

Origin Company_Name :
Jiangsu Hengrui Medicine Co Ltd

Active Company_Name :
Dr.Reddy’s Laboratories Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ifinatamab Epigenetic Reader Domain
Penpulimab Data Sheet
MAP2 Antibody: MAP2 Antibody is an unconjugated, approximately 60 kDa, rabbit-derived, anti-MAP2 polyclonal antibody. MAP2 Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts